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Abstract 
As pharmaceutical companies and conservation groups 
increasingly recognize the biomedical and economic po-
tential of indigenous medicines from tropical rainforests, 
romanticized stereotypes of rainforest medicines as inher-
ently beneficial abound. These ideas fail to take into con-
sideration the question of why those living in the rainfor-
est need medicines, and whether or not “traditional” medi-
cines are a “choice” to those who do not have access to 
pharmaceutical medicines. This paper presents a theoret-
ical analysis of how the study and practice of commodify-
ing indigenous medicines has tended to exclude the struc-
tural factors shaping their use in indigenous communities, 
drawing on 14 months’ ethnographic research on ac-
cess to medicines near the Ranomafana National Park in 
southeastern Madagascar. I suggest that researchers and 
practitioners of conservation and development consider 
the ways in which “modernizing” tropical rainforest com-
munities shapes patterns of health and illness unevenly, 
thereby contributing to changing medical “traditions.” 
Introduction
 
There is a wonderfully goofy scene in the 1992 mov-
ie “Medicine Man” in which leading man Sean Connery, 
somewhere deep in the jungles of the Amazon rainforest, 
is hard at work in a make-shift open-air bamboo labora-
tory, his long scraggly gray hair marking him as an aca-
demic wizard long gone native. One half expects a gangly, 
giggling Gilligan to stumble over the coconut-shell bowls 
of wonder-drugs that the professor had so painstakingly 
laid out amongst the cauldrons and test tubes that litter 
his lab, bringing the experiment to a tragic but touchingly 
comic end. Instead, the lovely and intrepid program officer 
whose agency has funded Connery (think Ginger in Ba-
nana Republic attire) has trekked through the jungle curs-
ing and squealing all the way, to see what on earth he’s 
been doing with all their money. She is both dismayed 
and touchingly smitten to find long lines of natives car-
rying their sick children to the good doctor for a dose of 
the miraculous cancer cure that he has concocted from 
local plants and native wisdom. Given that cancer is not 
exactly the number one killer in tropical zones, the scene 
left me wondering why the writers couldn’t have had the 
indigenous inhabitants bringing their malaria-stricken 
children for treatment with a wonder drug they actually 
needed. 
 
A similar perplexing scene was recently brought to the 
screen in the Dreamworks’ children’s movie “Madagas-
car,” where a trio of computer-animated zoo animals has 
washed ashore the Great Red Isle and encountered an 
anthropomorphic tribe of lemurs drumming and chant-
ing like blood-thirsty warriors, preparing to battle the car-
nivorous fosa that threaten their existence. While it was 
refreshing that the movie-makers hadn’t made impover-
ished Malagasy farmers the foes that threatened the sur-
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vival of the lemurs, I was left this time wondering why the 
lemurs couldn’t have been dancing to Malagasy music in-
stead of the Carribean beat of “Jungle Boogie,” and why 
in the world the movie had to include the line, “People? 
If there were people on this island, it wouldn’t be wild!” 
Despite its population of over 18 million, the image of the 
island as one uninhabited by people, just as the image of 
indigenous wisdom and rainforest medicines as romantic 
treasures needed to cure the cancers of the “developed” 
world, fits with certain cultural frames that shape our un-
derstanding of the tropical world, and it is through these 
understandings that social policies – and science – take 
shape.
Yet for all their ludicrous misrepresentations of tropical 
worlds, these movies are presented as entertainment and 
make no pretense at shaping public thought beyond Medi-
cine Man’s attempt to illuminate the importance of tropical 
medicines in improving human health. In contrast, while 
reaching a far more limited audience, but potentially hav-
ing a far greater impact on public thought, are comments 
presented on The Textbook League (TTL) website. At the 
time of this writing, TTL “was established in 1989 to sup-
port the creation and acceptance of sound school books,” 
and targets its publications to “classroom teachers, of-
ficers of local school districts, officers of state or coun-
try education agencies, and private citizens who take a 
serious interest in the quality of the instruction offered in 
the public schools.” TTL’s President, William J. Bennetta, 
known primarily for his vocal critiques against the teaching 
of creationism in the public schools, has pointed to Mada-
gascar’s Rosy Periwinkle as a classic example of environ-
mental and cultural romanticism passing as science. In an 
article entitled “Rain Forest Claptrap,” he writes,
The rain-forest claptrap in Holt, Rinehart and 
Winston’s high-school book Holt Health is espe-
cially bad because the Holt writers try to kill two 
toucans with one stone. In an article headlined 
“Cultural Diversity: Medicines From the Rain For-
est” they promote the common fancy that tropi-
cal rain forests are huge storehouses of pharma-
ceutical materials, and they also pander to the 
multi-culti mob by depicting rain-forest indigenes 
as medical savants (Benneta 1999).
Bennetta does raise an important issue concerning mis-
conceptions about “rainforest” medicines. Popular con-
ceptions of rainforest medicines are not necessarily based 
on empirical or scientific evidence, and while many indig-
enous healers possess a remarkable range and depth of 
knowledge about the biopharmaceutical properties of the 
flora and fauna in their environments, others may have 
very poor, if not potentially dangerous, knowledge of these 
properties.
 
Bennetta makes another significant point concerning Mad-
agascar’s famed “Rosy Periwinkle” (Catharanthus roseus 
(L.) G. Don.), which has achieved such renown that it was 
adopted as the symbol for the National Cancer Institute’s 
Research Symposium in 2003 (Tilghman 2004):
Various advocates for the preservation of the 
tropical rain forests have used C. roseus as a 
sort of poster plant and have falsely said that it 
is a rain-forest organism. . . . Propagandists also 
have distorted the history of the vinca alkaloids 
to spin a clever-aborigine tale: The discovery of 
the alkaloids is ascribed to scientists who re-
ceived help from Madagascan [sic] witch doctors 
– witch doctors who, it is implied, had recognized 
that C. Roseus exhibited antineoplastic activity . 
. . This tale exists in several versions. (Bennetta 
1999)
He continues by providing examples from the Tropical 
Conservation Newsbureau on the role indigenous sha-
mans of Madagascar (ombiasa) played in leading scien-
tists to the discovery of the plant which has been found to 
be effective in the treatment of leukemia, Hodgkin’s Dis-
ease, and other cancers. Bennetta’s point, that because 
the “witch doctors” used the plant to treat diabetes, yet its 
biomedical efficacy and commercial value is associated 
with its tumor-inhibiting properties, leads him to conclude 
that only Western scientists should be credited with the 
discovery of the plant’s true medicinal value. “Madagas-
can [sic] witch doctors were not in the picture anywhere” 
(Bennetta 1999). Indeed, it was not Malagasy healers who 
first brought attention to Western scientists of the plant’s 
biomedical potential. Tilghman (2004) details how the 
plant’s use for treating diabetes has been traced to both 
Caribbeans and Filipinos, rather than Malagasy, and that 
the plant grows throughout the world. Eli Lilly, the phar-
maceutical company which has profited by an estimated 
$160,000,000 annually from medicines derived from the 
Rosy Periwinkle, now obtains its supply of the plant from 
Texas (Tilghman 2004), while pharmaceutical companies 
throughout Europe, as well as others in the U.S., continue 
to import the plant from Madagascar, leading to “massive 
deforestation” for the cultivation of the Rosy Periwinkle for 
commercial export (Tilghman 2004:32).
Bennetta also points to the fact that Madagascar’s Rosy 
Periwinkle is celebrated as a “rainforest” medicine, cor-
rectly noting that it is not endemic to the rainforest; it grows 
more commonly in secondary growth. This fact points to 
a common fallacy about the rainforest as a “storehouse” 
of wonder drugs. Instead of relying upon forests for their 
medicines, many people living in tropical rainforests are 
more likely to use medicines from recently cleared areas 
rather than “old growth” or “pristine” tropical forests. In a 
review of the literature on medicinal plant use in the Amer-
icas, Stepp and Moerman (2001) found that in all but a 
few cases, the vast majority of medicinal plants used by 
indigenous peoples come from disturbed areas, such as 
along roadsides or in secondary growth. They attribute 
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this disproportionate use of secondary-growth environ-
ments over primary forest to two likely causes. The first is 
the issue of accessibility. Most indigenous people live in 
cleared areas rather than primary forest, so they would be 
more likely to use those plants that grow closer to home, 
than those that require trips to the forest. Accessibility may 
be further shaped by cultural factors relating to who has 
access. In the case of Madagascar, where I conducted 
ethnographic research on access to pharmaceuticals and 
forest medicines in the southeastern rainforest region of 
Ranomafana from 1995 - 1996, I found that because pre-
menopausal women are excluded from the forest, forest 
medicines were more commonly men’s resources, while 
locally grown plants and weeds were more commonly 
women’s medicinal resources (Harper 2002). Moreover, 
I found that because the village in which I resided was a 
virilocal one, in which women married and moved to their 
husbands’ villages from geographically distant regions, 
women brought a diversity of medicinal plant knowledge, 
thereby contributing to the development of a broad range 
of indigenous treatments. At the same time, as women 
passed on this ever-changing syncretic medical wisdom 
to their daughters and sons, men passed knowledge of 
their lineage’s prized and secret remedies to their sons, 
who would obtain their medicines from the same habitat 
(albeit an ever-shrinking one), as their ancestors. Thus, 
men and women possess differing knowledge domains of 
the forest in which they live, and the forest medicines they 
use. This differing access has also been noted by Shanley 
and Luz (2003) who observed that it is common for men to 
collect forest medicines, while women prepare them.
 
The other explanation Stepp and Moerman (2001) raise 
for the disproportionate number of medicinal plants found 
in secondary growth is that “weeds” are more likely to con-
tain toxins, making them biochemically effective as medi-
cines. Plants with long lives are more likely to develop im-
mobile defenses, such as thorns, to defend against preda-
tors, while those with short lives are more likely to develop 
biochemical compounds. Because plants that rapidly col-
onize an area tend to be fast-growing and short-lived, they 
are more likely to contain chemical defenses against pred-
ators. These chemicals exhibit the bioactivity that makes 
them efficacious as medicinals. Madagascar’s Rosy Peri-
winkle is among these fast-growing, short-lived “weeds” 
which exhibit the biochemical defenses that may be poi-
sonous to an insect, but can be medicine to a human.
 
Clearly, while condemning research on tropical medicines 
as the fluff of a “multi-culti mob,” Bennetta’s own political 
agenda to defend the superiority of Western science over 
indigenous science is unmistakable, and has the unfortu-
nate consequence of defending the unremunerated ap-
propriation of medicinal plant resources and indigenous 
knowledge. And by dismissing indigenous Malagasy heal-
ers as “Madagascan witch doctors,” unworthy of scientific 
attention, he comes across as less astute than Gilligan 
himself in grasping the potential for working with indige-
nous farmers and healers to learn the multitude of ways in 
which Western scientists can gain knowledge from those 
who live most intimately with the complex world of tropical 
flora and fauna. But his points that popular views of rain-
forest medicines are often unfounded and are shaped by 
romantic views of indigenous peoples as inherently wise 
are important ones. In this article, I explore these ideas, 
though toward far differing ends than those of Bennetta’s. 
 
Rather than viewing the celebration of tropical medicines 
and indigenous healers as “rainforest clap-trap,” in this 
paper I argue that as Western scientists seek to gain 
knowledge of tropical medicines and indigenous heal-
ing systems, we should pay greater attention to the ways 
in which we can extend access to biomedicine to those 
who live in the tropics, so that their children will not be left 
with tree bark to treat malaria and herbal teas for tuber-
culosis, while we in the richer world exfoliate our faces 
with vanilla-scented bath salts and seek new psychotro-
pic wonder-drugs to reduce our stress from urban living. 
After all, there very well may be cures for cancers and 
AIDS and the common cold deep in the heart of the Mala-
gasy forests, and indigenous healers may very well lack 
the knowledge or capacity to develop these cures. But by 
doing away with the romantic notion of “rainforest medi-
cines” as something “traditional” and therefore worth pre-
serving for indigenous people, and reflecting instead on 
the health needs of those living in the forests as every bit 
as important as the health needs of the rainforest “ecosys-
tem,” the possibilities of discovering these drugs may be 
that much closer.
 
Toward this end, I draw on my ethnographic research in 
the Ranomafana National Park region of Madagascar to 
extend Bennetta’s critique of the Rosy Periwinkle “poster 
plant,” toward a more detailed and complex exploration of 
why showcasing forest medicines as cultural commodi-
ties to be celebrated and preserved, while simultaneously 
promoting development programs that radically alter in-
digenous cultures, can contribute to social inequalities 
that have potentially deleterious effects on indigenous 
health. While in many cases plant medicines may provide 
affordable and effective treatments for minor disorders, 
and merit their preservation and respect, in far too many 
cases these celebrated plant medicines may do nothing 
more than provide the poor a bit of hope before they die 
– of diseases for which we have already discovered and 
developed effective cures that those on the road to “de-
velopment” in Madagascar (and beyond) cannot possibly 
afford.
Rainforest Clap-Trap Reconsidered
 
A prevailing theme in the popular and academic press has 
been that the forest is home to countless health resources 
– specifically, medicinal plants used by forest people for 
treating diseases and wounds, as well as providing nu-
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trition. And as Bennetta has correctly noted, Madagas-
car’s Rosy Periwinkle is used indigenously to treat dia-
betes; discovered by Western scientists to be an effective 
treatment for childhood leukemia, it is frequently pointed 
to as an example of the medical value of tropical forest 
plants, suggesting that there are untold other plant spe-
cies which can be used in the treatment of other cancers, 
heart disease and AIDS. In search of these undiscovered 
medicines, conservation planners and ethnobotanists are 
concerned with conserving the forest in order to preserve 
plant species, with exploring indigenous knowledge sys-
tems of how local forest products are used by healing 
specialists, and with investigating the cultural roles that 
plants play in indigenous communities.
 
To persuade local forest communities of this need, envi-
ronmentalists often appeal to local communities to sup-
port conservation objectives by suggesting there is poten-
tial profit in local forest medicines. They often suggest that 
money can be made locally if plants found to be of value 
to Westerners – either for medicines, perfumes, or beauty 
creams – can be marketed nationally or internationally. 
By pointing to the botanical research on medicinal plants 
to legitimate this aim as globally beneficial because it is 
of benefit to science, once issues of intellectual property 
rights are negotiated and settled – if they are at all – the 
quest for scientific knowledge of the forests’ rich pharma-
copeia is regarded as inherently humanitarian and mor-
ally justified.
 
While botanical research of forest plants does indeed 
make a substantial contribution to scientific knowledge 
and the treatment of many diseases, the scientific pro-
cess itself is deeply embedded in political concerns, not 
only in the questions that are asked – which plants are 
biomedically efficacious and therefore can be commod-
ified – but in which questions are not asked. Tropical 
plants used for healing are related to the social, political, 
and economic factors that shape the use of medicines in 
forest societies, and they benefit or harm those who are 
dependent upon them in different ways. Why people living 
in the forest need medicines, why they select plants and 
not pills, or why they choose pills and not plants, and how 
the quest for medicine is related to changing ecologies, 
land tenure, social structure, and economics, are ques-
tions that invite further exploration – questions that are 
not regarded by many policy makers as relevant to un-
derstandings of how the forest environment is related to 
the health of forest residents. The end result is that forest 
residents are expected to depend on indigenous medi-
cines for their health problems as if by “choice” or “tradi-
tion,” at the same time they are called on to offer up their 
medicinal knowledge for sale or gift to outsiders, while re-
ceiving no comparable or real access to the pharmaceuti-
cal medicines of the industrialized world.
 
One reason issues of social structure, economics and 
politics are not considered by some as germane to the 
anthropology of medicinal plant use, is that the marriage 
of botany to social science has in many respects focused 
on how plants are used and valued within the indigenous 
medical system. This focus has relied almost exclusively 
on either a biological framework (toward understanding 
the biological value of plant medicines), an interpretive 
framework (toward understanding the symbolic value of 
plants to those who use them) or a synthesis of the two 
(e.g. Balick et al., Etkin 1988). Davis (1995) summarizes 
how the merging of ethnobotany and anthropology has 
evolved:
Increasingly as ethnologists joined the field, 
the emphasis shifted from the raw compilation 
of plant names and uses to an intellectual per-
spective that viewed the character of a peo-
ple’s relationship with the plant world as but 
one means of approaching an understanding 
of the cognitive foundations of a culture. . . . . 
As anthropologists working in ethnobotany be-
came concerned with the “totality of the place of 
plants in a culture” (Ford 1978), the intellectual 
potential of the discipline began to be realized. 
The study of plants became a vehicle for ad-
dressing general issues of ethnological signifi-
cance. Several themes emerged. The important 
concept of cultural relativism was reinforced by 
studies of folk classification, which revealed that 
aboriginal taxonomies, while not necessarily co-
inciding with Linnean concepts and categories, 
were equally complex and firmly rooted in biol-
ogy (Conklin 1954; Berlin et al. 1974). Studies 
of hallucinogenic plants offered insights into the 
origin and character of complex religious beliefs 
(La Barre 1938; Reichel-Dolmatoff 1971, 1975). 
Work in medical anthropology highlighted the 
significance of non-Western concepts of health 
and healing and, in doing so, emphasized the 
elaborate connection between spiritual belief, 
psychological predisposition, and pharmacology 
that underlies all indigenous practices involving 
psychotropic preparation (Davis 1995:43).
Although focusing on the biological and interpretive di-
mensions of botanical medicines provides critical insights 
into their local use, such a focus, when it remains isolated 
from the historical context and the political economy of 
medicine use, is problematic. Apart from a focus on bi-
ological efficacy, by conceptualizing the cultural context 
of medicines as the cosmological and social meanings 
of medicines, one is almost forced to think in terms of a 
shared concept of reality grounded in a common history 
and undivided interests. But social categories of class, 
caste, gender, age and ethnicity shape the social sys-
tem in such a way that communities are united not just 
through shared interests and knowledge, but through 
conflicting ones as well.
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By stepping outside the “medical system” to focus on in-
dividual and social differences, one is brought closer to 
understandings of power and the relationship between 
power and knowledge. Power permeates all dimensions 
of a society. These dimensions, however, are not distinctly 
bound. Medicine is fused with agriculture, just as agricul-
ture is fused with religion. And these differing but intercon-
nected social dimensions and power relations continually 
change. When explored in relationship to changing envi-
ronments, social and environmental change are linked by 
concepts of power – who has, and who does not have, 
the power to mediate change? I ask this question to draw 
attention toward an understanding of how environmental 
and land-use changes (such as deforestation or the es-
tablishment of protected areas) do, in fact, change the use 
of forest medicines for different people, but not in uniform 
ways.
Disentangling “Culture” From 
the Culture of Medicine
 
The role plants and other botanical resources play in the 
health and well-being of humans is indisputable. But be-
yond the immediate perceptions one may form regarding 
the contribution botany makes to society, there remain 
more subtle, and more complex, dimensions to this rela-
tionship. To understand this relationship in greater depth, 
one must consider the ways in which public perceptions 
of the relationship between forest medicines and society 
have been shaped by both academic and commercial 
concerns.
 
Much of the focus on the cultural context of medicines 
in indigenous communities subjected to conservation or 
development intervention is made by people trained in 
the natural sciences or public administration, who often 
conceptualize culture as something others have, some-
thing that is exotic, shared by all members of “the tribe,” 
and fixed in tradition. At best it is agreed that it is impor-
tant. Indeed, in the best tradition of the missionaries of 
the nineteenth century, understanding culture is seen by 
many twentieth century international aid workers – hoping 
to “improve” economies, environments, and health – as a 
prerequisite to the success of changing that culture. In the 
following quote, a nineteenth century missionary suggest-
ed that ethnological knowledge of the Malagasy would fa-
cilitate enlightenment and economic change:
There still, however, remains a very marked gap 
in, at least, our English literature treating of the 
Malagasy ethnology: we know hardly anything 
definite about those numerous wandering tribes 
which are popularly known under the name of 
Sakalava. . . . . Under enlightened and upright 
Hova governors, the Sakalava country would re-
cover its prosperity, commerce would be opened 
up, and the vast agricultural resources of the 
western provinces would be developed. And last, 
but not least, Christianity would be introduced, 
and the people lifted up from their present hea-
then condition into the light and liberty brought 
by the Gospel of Christ. We still, however, need 
much information about the Sakalava tribes (Si-
bree 1878:456-457,468).
One hundred and sixteen years later, a United States 
Agency for International Development (USAID) report re-
flects little change:
Local customs, traditions and cultural variations 
can be an obstacle to both conservation and de-
velopment objectives. The RNPP [Ranomafana 
National Park Project] will make every effort to 
identify these forces and work with the recog-
nized community structures to accomplish the 
objectives that benefit both the communities and 
the park. Local knowledge will be incorporated 
into all aspects of the project to heighten the 
chance of success of activities (RNPP 1994:86).
 
These quotes, which are typical of development discourse, 
suggest that the way the concept of culture has been em-
ployed by those seeking to “understand” other cultures 
has not necessarily been toward the enlightenment of out-
siders, as much as it has been viewed as something to be 
done away with and replaced with the cultural paradigms 
of more politically powerful groups. Such a view is directly 
at odds with anthropological concepts of culture, in which 
preservation of cultural integrity is a primary concern, with 
culture seen as “that complex whole” that includes eco-
nomic structures, social organization, cultural institutions, 
and power relations, in addition to “traditions” and symbol-
ic systems. Understanding the distinctive ways in which 
the term and concept of “culture” have been used by peo-
ple from varying disciplines and professions may clarify 
anthropological approaches to the study of culture, health 
and the environment.
There are two primary ways that forest medicines, or me-
dicinal plants, are viewed by those who do not live in the 
forest (whom I term “outsiders”). One view regards forest 
medicines as resources to be commodified. As the multi-
national pharmaceutical industry expands its drug market-
ing globally, the commodification of tropical resources by 
capitalist enterprises also accelerates. With this expan-
sion of the profit-oriented medicine industry, the concept 
of “traditional” has been reduced to that which is of little or 
no economic value to industrialized nations.
 
At the same time, ecologists and ethnobotanists pres-
ent a second view. In the name of biodiversity and as a 
strategy and goal of sustainable development, they call 
for researching and preserving traditional medicines, and 
the indigenous knowledge systems concerning their use. 
McCaleb (1997:221), for example, suggests that plant 
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medicines may be the only sustainable form of medicine, 
because it is not only readily available to people in the “de-
veloping” world, but because it also has a rapidly growing 
market in the industrialized world.
 
Warren (1997) indicated that research on the medicinal 
properties of plants is integrally linked to sustainability of 
environmental development through a focus on indigenous 
knowledge. Indigenous knowledge, he argued, is an impor-
tant national resource; by recognizing intellectual proper-
ty rights to profits from medicinal plants, and by including 
those knowledgeable as participants in the commodifica-
tion and marketing of plants, medicinal plants become a key 
symbol to sustainability.
 
While the sustainability and equitable distribution of profits 
from bioprospecting and commodifying indigenous medi-
cines is both ethical and crucial, this line of intellectual query 
ignores the economic benefit forest residents may receive 
from burning the forest, leading to health benefits which in 
many circumstances may offset the loss of medicine. Con-
sequently, the local context in which forest cover is inten-
tionally cleared must be considered along with ethnographic 
inquiry into how medicines are used by forest residents. Et-
kin (1996:163) draws attention to the significance of explor-
ing the local context of how indigenous plants are used both 
for medicine and for nutrition:
At present, the rate and extent to which genetic 
resources are being depleted worldwide threatens 
species extinction to an extent never before expe-
rienced in human history. This issue has become 
increasingly politicized as resources, largely of the 
“developing” world, are deliberated from a variety 
of Western postures, predominantly economics 
(Morowitz 1991). “Important” or “interesting” spe-
cies tend to be defined by polities that are culturally 
and politically not engaged with the threatened en-
vironments and the people who inhabit them. Thus, 
the value of particular taxa has not been adequate-
ly assessed in the local contexts of their use. In-
stead, conservation efforts generally focus on food 
crops, ignoring “wild” foods and other resources 
– notably medicines and other plants whose sa-
lience does not bear directly on the expertise and 
interest of outsiders. Some recent efforts to ad-
dress biodiversity issues through a focus on me-
dicinal plants (e.g., Farnsworth and Soejarto 1991) 
still betray a Western bias that values knowledge 
of plants for potential development by the pharma-
ceutical industry.
 
Without such ethnographic understanding of the local con-
text, the extent to which the loss of plant medicines affects 
those who live in the forest is not clear. More attention has 
been drawn to the potential “global” loss of medicines – that 
is, the loss to biomedicine and pharmaceutical corporations 
– that deforestation might cause, than to how loss of forest 
biodiversity is or is not associated with the loss of medi-
cines for forest residents (e.g. McCaleb 1997, Plotkin 1993, 
USAID 2001, World Bank 1994).
 
This focus on the preservation of biodiversity as a moral-
ly righteous objective has indeed been seized by the phar-
maceutical industry seeking Third World resources for First 
World drugs. Their focus on “traditional” medicine has two 
objectives. One, to gain knowledge about the unknown med-
ical system in order to appropriate both the knowledge and 
the resources for profit, and two, to gain knowledge about 
the unknown medical system in order to tap new markets for 
pharmaceuticals. This knowledge and these resources thus 
obtained become “modern,” whereas what is left behind as 
of no use, or what remains undiscovered by biomedical re-
searchers or unfamiliar to them, is “traditional.” This dichoto-
mized ideology presumes that there is no tradition in mod-
ern allopathic medicine, nor anything modern in indigenous 
medicines.
 
To bridge this gap, some medical anthropologists have 
called for more attention to medical pluralism, as opposed 
to studies of medical “systems.” While Stoner (1986) has 
charged that the “medical systems” have become dichoto-
mized as “folk” or “modern,” ignoring the multiple forms of 
medicine that practitioners employ to heal the sick, Coma-
roff (1983) and Stoner (1986) have critiqued the concept of 
medical system itself for the ethnocentric bias inherent in 
separating the medical from other social dimensions. Co-
maroff charges that the scientific quest for categories (within 
the medical system) is itself ethnocentric in that it presumes 
such categories to exist, and that the distinction of various 
social domains, such as religious, economic, or medical, are 
recognized as separate domains among the people whose 
medical system is studied by the ethnographer.
 
Baer et al. (1997) suggest that medical pluralism is not in-
digenous to pre-state societies, but is instead, directly asso-
ciated with increasing social stratification. They indicate that 
the role of shaman is central to the dyadic core (healer-pa-
tient relationship) in simple preindustrial societies, whereas 
in horticultural societies one finds multiple specialists utiliz-
ing varying components of the folk medical system. In in-
dustrial societies, the authors suggest, the biomedical phy-
sician dominates a myriad of medical systems. They further 
contend that the concept of medical pluralism is perhaps 
better understood as medical dominative systems, in which 
biomedicine dominates all other systems.
 
While not disputing the association between increasing lev-
els of social stratification and increasing medical specializa-
tion, I would suggest that this view reifies in some respects 
the folk/modern dichotomy by its reliance on subsistence 
strategies as boundaries separating “simple preindustrial” 
foraging, horticultural, and state industrial societies. In real-
ity, multiple subsistence strategies are practiced in all soci-
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eties and all societies have been incorporated into states. 
Moreover, although certain subsistence strategies may 
predominate in societies, this does not necessarily mean 
that they are uniformly practiced by all community mem-
bers. 
Quests for Medicines Near Ranomafana 
National Park, Madagascar
 
The Ranomafana region of southeastern Madagascar 
provides a telling example of how misconceived ideas 
of culture obscure useful understandings of how medi-
cal systems are associated with economic systems. The 
Ranomafana National Park was established in 1989 to 
protect endangered native species and preserve forests 
threatened by swidden (“slash and burn”) rice farming; 
the Ranomafana National Park Project (RNPP) was es-
tablished the following year as an Integrated Conserva-
tion and Development Program (ICDP) funded by USAID 
to manage the park.2 While indigenous farmers have been 
prevented from continuing their “cultural traditions” of swid-
den farming (tavy) and entering the forest, pharmaceuti-
cal research on medicinal plants is encouraged as a form 
of sustainable development. Local residents have been 
characterized as practicing “traditional” farming methods, 
and characterized according to perceived ethnicity as ei-
ther Tanala or Betsileo. The Tanala have been character-
ized as “traditional” tavy farmers, reluctant to change their 
ways, while the Betsileo have been characterized as more 
“modern” wet-rice agriculturalists and more amenable to 
“modern” farming methods and lifestyles (Harper 2002). 
Along with these characterizations, local Malagasy are 
viewed as practicing “traditional” medicines, one of the 
few cultural practices that the Project has regarded as 
worthy of respect (Harper 2002, RNPP 1994), while use 
of pharmaceutical medicines and biomedical health care, 
which is virtually unavailable to the majority of residents, 
is regarded as a marker of modernity.
 
Yet all local residents are tied to the market and tied to the 
state, and engage in multiple subsistence strategies, from 
foraging to irrigated agriculture; these practices, in turn, 
affect their health and access to medicines in different 
ways. A series of economic strategies, including structur-
al adjustment programs imposed by the World Bank, the 
prohibition of forest farming and other uses through the 
establishment of the park, and poorly planned develop-
ment projects all contributed to intensified poverty for the 
majority of residents, while a few residents benefitted sub-
stantially (Ferraro 2002, Harper 2002). During the fourteen 
months in which I resided in one of the RNPP pilot villages 
(targeted for development projects), ten percent of the vil-
lage population died, most of them from what were seem-
ingly treatable diseases such as malaria and tuberculo-
sis, while project administrators did nothing to explore any 
possible connections between these economic changes 
and the high death rate, regarding the deaths as “natural” 
and the residents as practitioners of “traditional” medicine 
and hence, unwilling to seek “modern” health care (which 
was unavailable to most of them). Through a “willingness” 
to “modernize,” and more specifically, use pharmaceuti-
cal contraception, residents would become more healthy, 
project administrators reasoned.
 
To classify the Malagasy as practitioners of folk and/or 
modern medicine, as they have been by project adminis-
trators (Harper 2002), is as misleading as classifying them 
as swidden or irrigated rice agriculturalists. Their society 
has, nonetheless, changed significantly as wage labor be-
comes far more central to the economic base, at the same 
time residents have resisted efforts by outsiders to aban-
don foraging and horticultural practices in favor of irrigated 
agriculture. In other words, while the organization of labor 
is rapidly changing, the mode of subsistence is changing 
at a much slower pace. The increasing social stratification 
in the Ranomafana region that has ensued is more closely 
related to the changing structure of the economy than it 
is to the mode of subsistence, or infrastructure. It is this 
changing economic base, I argue, that is contributing to 
medical pluralism and inequalities in health and well-be-
ing, rather than the shift to irrigated agriculture per se, or 
the process of “modernization.” 
 
Biomedicine may well predominate in stratified societies, 
in that it is more desirable for certain people in the treat-
ment of certain disorders, but it does not always predomi-
nate, even in industrialized countries where “alternative” 
“natural” and “folk” medicines or health care are common-
ly utilized by members of all social strata. Likewise, while 
an emphasis on the hegemonic influence of biomedicine, 
particularly with regard to the commodification and distri-
bution of pharmaceuticals, is important to understanding 
how biomedicine is incorporated into post-colonial societ-
ies and viewed by community members, such an empha-
sis can obscure an equally imperative emphasis on how 
biomedicine is often superior to plant medicine in treating 
many critical health issues – notwithstanding the fact that 
it is often injurious as well. It is for this reason that the 
World Health Organization (1988) has called for the eq-
uitable distribution of essential medicines throughout the 
globe.
 
Nonetheless, distinctions of “folk” and “modern” con-
tinue to be reproduced by the professional and popular 
cultures, and are put into practice by many physicians, 
development workers, and corporate investors, as they 
gaze upon medicines as tools toward their respective ob-
2. Management has since shifted to the World Bank-funded Association National pour la Gestion des Aires Protégées 
(National Assosciation for the Management of Protected Areas).
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jectives. Yet rather than remaining in discreet domains 
of folk or modern, pharmaceutical medicines have freely 
entered into indigenous medical systems with the same 
ease in which herbal medicines find themselves stocked 
alongside aspirin and antihistamines at the local Rite Aid. 
In Madagascar, I found “calcium” was regarded by many 
as a general nutritive supplement to ward off disease. At 
the same time, antibiotics were regarded as an all-purpos-
es cure-all for everything from malaria to sickness sent 
through witchcraft (the latter requiring, of course, the ad-
ditional medicines of an ombiasa, or diviner/healer). Over 
a decade ago, van der Geest and Whyte (1988:10,11) al-
luded to this problem of syncretic medical systems chal-
lenging our cognitive categories:
In situations of pharmaceutical pluralism, terms 
like “traditional” and “modern,” “indigenous” and 
“Western” medicines are almost unavoidable. 
So are the quotation marks around these terms. 
There is an uncomfortable sense that they are 
misleading, since the pluralistic context trans-
forms both imported and native medicines. Thus 
we find “modern” medicines being distributed by 
“traditional” healers and utilized in ways never 
imagined by the manufacturers. Penicillin may 
become an ancient Ayurvedic medicine. And we 
see “indigenous” medicine being manufactured 
on an enormous scale advertised on television, 
and exported to other countries. Genuine jamu3 
from Indonesia can be purchased in Europe. The 
nuances involved here may serve to remind us 
once more of the care needed in the use of terms 
like traditional and Western medicine.
 
Concepts of “traditional” medicine are not just imposed 
on indigenous societies by outsiders from the industrial-
ized world. They are just as likely to be perpetuated by 
outsiders from within post-colonial nations – that is, ur-
ban-based, Western-educated elite. Feierman (1985) 
suggests that there is an assumption in the medical an-
thropology research that “traditional” African medicine is 
something that “traditional” Africans do. This assumption 
is facilitated, in part, by the social status of those Africans 
who write about African medicine. Feierman points out 
that focusing on the competition between popular and bio-
medicine draws attention away from more critical ques-
tions, such as how are social costs distributed, what is the 
relationship between production and health, and how do 
social changes pattern health and disease?
 
Despite the convenience of distinguishing between “tradi-
tional” and “modern” medicine, and despite the seeming 
contrast between the domains, it is important to explore 
the political and economic forces that shape any concept 
of “medicine.” In so doing, it becomes apparent that re-
gardless of whether a medicine is found in the backyard or 
in a child-resistant plastic bottle, medicines are resources, 
and as resources, distinguishing them according to their 
material form may not tell as much about the person taking 
them as does distinguishing them in terms of their political 
and economic form. Taussig (1980) has shown how the 
social products of our world become so naturalized that 
the social order related to their production and commodifi-
cation escapes our senses entirely. Indigenous medicines 
are symbolic of a social order that extends beyond the 
natural world into the world of medicines as profit.
 
Nonetheless, the political and economic forms of medi-
cine used by forest residents are rarely addressed by 
those who study them, except to the extent they are pre-
sumed to be profitable. This is because a second view 
many bring to the study of forest medicines is deeply em-
bedded in Western views of what constitute such medi-
cines. This is the view that forest medicines – primarily 
conceptualized as plant medicines – are natural healing 
agents from the forest’s rich cornucopia of biodiversity. 
They are, as such, “good things,” “natural,” and potentially 
enriching both in terms of health and wealth.
A growing segment of the public believes that 
herbal medicines and other alternatives are saf-
er, possibly more effective, more natural, and 
more in harmony with a lifestyle that promotes 
self-care, individual responsibility, freedom of 
choice, and “holistic” thinking. A part of this too 
is the belief that a return to more natural thera-
pies is a return to the time in which our medi-
cines, like our foods, came from the earth, and 
the use of these natural substances is more in 
harmony with our natural surroundings (McCa-
leb 1997:228,229).
A third view is that increased population pressure leads 
to increased deforestation of the tropics; as forest resi-
dents increase swidden agriculture on a limited land base, 
they encroach on old growth rainforests. This view is ad-
vanced by many conservation and development planners 
who are concerned with halting the destruction of tropi-
cal forests, and is central to the environmental and health 
policies of the World Bank and the United States Agen-
cy for International Development. This view holds that if 
women who live and work in tropical forests adopt family 
planning practices, and have access to improved prenatal 
and infant health care, forest populations will decrease, 
and forest residents will no longer need to clear more for-
ested land. This idea focuses more on how the health of 
people affects the health of the forest, presuming as well 
that what is good for the forest (conservation) is good for 
its inhabitants. 
 
3. Jamu is an indigenous medical system of Indonesia, and employs herbal medicines as a primary mode of illness 
treatment.
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Conservation planners and ethnobotanists consequently 
are concerned with conserving the forest in order to pre-
serve plant species (e.g., Middleton et al. 1993), with ex-
ploring shared indigenous knowledge systems of how lo-
cal forest products are used by healing specialists (e.g., 
Naranjo 1995), and with investigating the cultural roles 
that plants play in indigenous communities (e.g., Alcorn 
1995).
 
Throughout the world, the pharmaceutical industry and 
others have capitalized on the conservation movement in 
order to maximize profit. Yet the merging of the objectives 
of the pharmaceutical industry with those of environmen-
talists is commonly represented as being so potentially 
fruitful, that an alliance which in decades past would have 
struck many as inherently conflicting, is now viewed by 
many environmentalists as symbiotic and “natural.”
Among the companies which have embarked on major 
medicinal plant research programs are Merck, Bristol My-
ers, Squibb, Pfizer, Monsanto, Smith Klein Beecham, and 
Eli Lilly. The interest of these companies in as yet undis-
covered medicinal plants – or rather, the compounds from 
medicinal plants – is a testimony to the importance of pre-
serving biodiversity as a source of future medicines.
This area of research on the part of ethnobotanical sci-
ence has also been criticized for its focus on the commer-
cial potential for Western profit, in which the research itself 
is value laden but couched as “universal” benefits by way 
of “discovering” potential cures for disease (Davis 1995). 
Nonetheless, as Gare (1995:79) points out:
Through treating things as commodities, the 
natural conditions for human creativity become 
private property and are then treated as capital, 
while people’s creative potential is reduced to la-
bor power to be bought and sold on the market.
Nowhere is this truer than in the focus on plant medi-
cines as having monetary value. Such a focus on how 
plant medicines can be commodified is intended to trans-
form the labor of local communities toward just such ends. 
Medicines viewed as economic resources, exclusive of 
their social and symbolic resource value, are in this way 
synonymous with medicines as property, to be bought and 
sold for profit, and the local medical experts reduced to 
labor power. 
 
As countries like Cameroon begin to see the 
economic value of the medicinal plants in their 
forests, they can better appreciate the foolish-
ness of clear-cutting those forests for timber, 
ranching, or mining. In fact, one of the strongest 
hopes we have for saving the ancient forests is 
that their true economic value will now be recog-
nized (McCaleb 1997:236).
According to the U.S. Agency for Internation-
al Development, the greatest challenge facing 
most farmers in developing countries is finding 
markets for crops with sufficient value to sustain 
a family business. In many parts of the world, 
agroeconomic development has shifted away 
from subsistence farming toward the search for 
specialty crops and cash crops which can be 
grown on farmland which is currently idle (Mc-
Caleb 1997:234).
Thus, the view of forest medicines as inherently good and 
natural goes hand-in-hand with the global marketing of 
forest medicines. Yet globalization contributes to increas-
ing social inequality throughout the world (Gunter & van 
der Hoeven 2004), and the increasing reliance on a mar-
ket economy, along with the deleterious effects of struc-
tural adjustment policies on Malagasy farmers, has rap-
idly intensified social inequality in Madagascar (Hanson 
1997, Harper 2002). Nonetheless, current environmental 
policies in Madagascar largely ignore social differences 
and local and national histories in favor of simplistic views 
that swidden rice production is destroying the forests, it is 
practiced due to tradition and poverty, and that by educat-
ing forest farmers in the practice of irrigated rice produc-
tion, and increasing their integration into a market econo-
my, they will act rationally which is to say, adopt the new 
technology and abandon their (irrational) cultural tradition 
(RNPP 1994, USAID 2001).
 
Likewise, the World Bank presumes that by investing in 
human resources, such as health and education, the eco-
nomic goals of promoting a free market economy in post-
colonial nations will be achieved:
Experience has shown that farmers who have 
had some primary education achieve higher 
yields, because they are more receptive to mod-
ern methods and are better able to communicate 
with their suppliers. . . . Health also has obvi-
ous impacts on productivity – healthy farmers 
can work harder, go further to markets, and so 
on (World Bank 1994:23).
In short, the linking of health and environment is tied to 
economic objectives which very much mimic the objec-
tives of colonial states which promoted health and repro-
ductive care in order to ensure a productive labor pool. 
These ideas, that agricultural or health practices are tied 
to tradition and custom, and can be untied through West-
ern education and introduction to the modern world of 
technology and chemistry, remain top-down. They do not 
constitute a form of “cultural exchange” in which educa-
tion is seen as reciprocal, and indigenous views, behav-
iors and objectives are regarded as rational, without nec-
essarily being in need of change by outsiders. Instead, 
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tradition is invoked as an obstacle to modernization.4
Generally, educating the people was seen as a 
crucial prerequisite to development. Education in 
fact plays a huge role in how people see environ-
ment and how willing they are to try something 
new. In a society where the ancestors are of tre-
mendous importance and traditions are greatly 
respected it is difficult to reason why old prac-
tices should be changed. Through education and 
raising the general state of awareness it is more 
likely that the old ways will be questioned and 
changed. People seem to look back more than 
forward, which is common in agricultural societ-
ies. Planning and creating future schemes are 
not part of the culture. Also a great belief in faith 
prevents people from talking full responsibility 
of [sic] their actions and their lives (Lappalainen 
2002:51).
The fixing of people’s beliefs and behaviors as traditional 
further presumes that they lack the ability to make choic-
es without enlightenment from outsiders (Feeley-Harnik 
1995). The desire to reap the rewards of the market econ-
omy, however, is presumed to be so universally innate 
that a project need only facilitate its integration into lo-
cal economies in order for the culturally-bound native to 
“choose” to participate.5
Based on the knowledge that the African environ-
ment and rural economic growth are inextricably 
linked USAID programs focus on helping Afri-
can countries get the conditions right for broad 
scale investments in practices and systems that 
increase productivity and reduce environmental 
degradation (USAID 2001:1)
The principal U.S. interest in Madagascar lies in 
the high potential of its people to break out of 
poverty to become one of Africa’s emerging mar-
ket economies, thus enhancing its ability to man-
age its globally unique biodiversity. Assistance 
to Madagascar serves U.S. interests by helping 
establish a legal and policy environment that en-
courages private initiative and investment, foster 
greater respect for human rights and the rule of 
law, and increases decentralized responsibility 
for decision making. Assistance to Madagascar 
also advances U.S. interests by helping the Mal-
agasy people to manage effectively one of the 
earth’s most extraordinary sources of biodiver-
sity. . . . All of these factors contribute to inte-
grating Madagascar into the world economy and 
in turn building its capacity to assume a greater 
partnership role in support of United States inter-
ests (USAID 2001:1).
The potential for economic gain from the rainforest has 
not been overlooked by those seeking to conserve it. 
As noted earlier, the importance of Madagascar’s indige-
nous plants to international pharmaceutical research and 
development is well documented. The Malagasy periwin-
kle, containing a chemical used to treat Hodgins [sic] dis-
ease and childhood leukemia, benefits millions of people 
worldwide. Natural chemical compounds found in many 
plant species provide vital components for the treatment 
of disease. Because of the tremendous plant biodiversity 
found in the remaining rainforests, it is likely that plant 
species known by western science to be biomedically ef-
ficacious, or species which are as yet undiscovered or un-
explored by western scientists, exist in the Ranomafana 
area (RNPP 1994:35).
What such promotional campaigns for research and de-
velopment fail to address, however, is that the commercial 
potential of medicinal plant bioprospecting rarely extends 
to those communities most impacted by conservation ef-
forts. As Tilghman (2004) has shown for Madagascar, and 
others (e.g. Brush & Stabinsky 1996) have shown through-
out the world, intellectual property rights and distribution of 
profits are complex and contentious issues, with disputes 
over ownership and proprietary rights challenged locally, 
nationally and internationally, leading to ethical and legal 
controversies far beyond the scope of this paper.
4. This is not to suggest that all cultural practices or “traditions” are inherently superior to “modern” ones, nor 
that “modernization” is inherently bad. Indeed, the central argument of this essay is that access to the benefits of 
modernization ought to be more equitably dispersed, and that in many respects modern pharmaceutical medicines 
are far more efficacious than indigenous medicines. Nevertheless, modernization is too often conflated with increasing 
consumption of Western goods and incorporating indigenous peoples into a low-waged labor pool that fails to provide 
subsistence, while profits from the resources and labor of indigenous communities leave the community and all too 
often, the nation and continent.
5, Integration into a market economy was central to the development objectives of many Integrated Conservation and 
Development Projects (ICDP’s), including the Ranomafana National Park Project, and continues to be the foundation 
on which conservation aid from the United States is based. Further integration into the market economy, and hence, 
consumption of resources, is regarded as something that will contribute to the conservation of resources.
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Let Them Eat Plants: Medicines 
and Human Rights
 
Physician and anthropologist Paul Farmer has pointed 
to the ways in which “cultural” explanations are offered 
to account for health treatment strategies that obscure 
social inequalities preventing many people from access-
ing modern medicines. In discussing the case of a young 
Haitian woman suffering from malaria, and whose father 
had her removed from a health clinic because he believed 
her illness was caused by witchcraft, Farmer asks:
Do these events speak to the power and integri-
ty of Haitian cultural traditions? Or do they point 
instead to inequalities of access which mean 
that, in rural Haiti, understandings of acute in-
fectious disease even now evolve largely in the 
absence of effective interventions that are read-
ily available to non-poor Haitians? Is Marie’s a 
story about rural “beliefs” or rather a story about 
poverty and its effects on health outcomes 
among people who share her circumstances? 
I’ve spoken about “selective blindness.” When 
an observer witnesses the effects of structural 
injustice and sees little more than cultural differ-
ence, is this not a conflation of cultural difference 
and structural violence? (Farmer 1999:154).
 
The tendency to view indigenous systems as passively 
responding to the pressures of capitalist society is also 
reflected in medical anthropology studies of indigenous 
societies that romanticize indigenous medical practices 
as innately practical, beneficial, and adaptive, while capi-
talist medicine, or biomedical systems, are portrayed as 
innately impractical, harmful, and maladaptive. For ex-
ample, while detailing the many ways in which indige-
nous Mayan childbirth practices provide a culturally-ap-
propriate and woman-centered birthing experience, Jor-
dan (1993) indicts biomedicine for creating a childbirth 
experience that ignores the needs and concerns of wom-
en, relies almost exclusively on biomedical technology 
that is presented as more harmful than helpful, and sub-
ordinates the knowledge of the indigenous practitioner, 
or the woman giving birth, to the authoritative knowledge 
of the biomedical practitioner. Her critiques are important 
ones and her cross-cultural analysis (in which she com-
pares birthing systems in four different cultures) is both 
rare and enlightening. But as Rhodes (1996) has shown, 
biomedicine is itself a cultural system, and as such, it 
merits respect and consideration. By drawing such broad 
conclusions about biomedicine, as Jordan did, one disre-
gards the ways in which biomedicine can improve infant 
and maternal mortality and health. With up to 300,000 
women in indigenous societies dying from complications 
associated with “natural” child birth each year, the issue 
of human rights may be more pressing than that of cul-
tural relativity or even cultural survival when analyzing 
indigenous medical systems in the context of capitalist 
medicine (see Farmer 2005).  
 
In more recent work, anthropologists drawing on political 
economy of health approaches, or critical medical anthro-
pology, have recognized that as much as biomedicine is 
a hegemonic cultural system, it is also in many ways, an 
efficacious one. For example, Millen et al. (2000) sug-
gest that globalization has intensified social inequality, 
and that health indicators provide the most telling evi-
dence for the uneven effects which economic and politi-
cal changes have had on the world’s population. They in-
dicate that as technology and knowledge have increased 
significantly in the field of health, access to this technol-
ogy and knowledge remains limited to certain groups of 
people. For those who lack such access, health care is 
not only limited, but health status remains low. For exam-
ple, malnutrition affects 11.2 million people in the United 
States, and 828 million in post-colonial societies. Rec-
ognizing that proper nutrition helps to prevent disease, 
the authors point out that half of the 31,000 children un-
der five who die each day, half die from hunger-related 
causes. In Africa, these rates have more than doubled 
since the mid 1980’s, a period which coincides with the 
introduction of economic liberalization and structural ad-
justment programs.
 
Millen et al. (2000) conclude that indicators of economic 
growth must include health indicators, and that these in-
dicators must consider multiple criteria, such as access 
to safe drinking water and sanitation, safe and appropri-
ate housing, and disease prevention. Utilizing aggregate 
statistics to portray overall health status of a population 
may obscure the ways in which gains in some areas are 
offset by declines in others.
 
Contrary to presenting biomedicine as a hegemonic 
medical system that undermines indigenous medical sys-
tems, Kim et al. (2000) present a number of case stud-
ies drawing on a political economy of health perspective 
which contend that biomedicine saves lives, and that po-
litical and economic development which intensifies the 
separation of the rich from the poor and makes access 
to this biomedicine the privilege of the minority, is unten-
able and immoral, a point that Farmer (1999) eloquently 
makes in his discussion of how treatable infectious dis-
eases such as tuberculosis continue to kill millions of 
poor people every year.
 
While Morsy (1996:27) suggests that connecting “poor 
health to the inaccessibility of “Western” medicine ob-
scures the connections between the local, national and 
international levels,” Kim, et al. (2000) contend that in-
accessibility to pharmaceutical medicines does contrib-
ute to poor health, and that lack of such medicines alone 
does not explain poor health. Other significant processes 
contribute to poor health, including economic changes 
imposed by national and international governments and 
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institutions, as well as local power relations, and the cul-
tural context in which the body and the environment are 
experienced and made meaningful.
 
Conceptualizing “forest medicines” or “indigenous med-
icines” therefore requires acknowledging the political, 
economic, and structural forces that accompany “tradi-
tion” and lead one group of people to rely upon plants 
to treat life-threatening disorders, while access to West-
ern pharmaceutical medicines is denied them. For exam-
ple, I found that while chronic illnesses were more likely 
to be treated by pharmaceutical medicines among forest 
residents who had access to land and labor, those who 
lacked such resources were more likely to ignore chronic 
illnesses, often leading to early death. At the same time, 
even those with access to land, labor and pharmaceuti-
cals, died from acute disorders, such as those that ap-
peared to be liver disorders. The profound disinterest of 
RNPP managment in exploring the factors contributing to 
these illnesses and deaths, however, limited any conclu-
sions that could be made.
 
Finally, in order to understand the suffering that indige-
nous medicines are intended to treat, one must include 
the social suffering that accompanies the suffering of the 
body when the patient knows full well that when sick, the 
indigenous healer may draw on the same pharmacopeia 
as the patient, but the Western physician’s own ailments 
are treated from a broader range of medicines often times 
more likely to cure but less likely to provided to the poor, 
due to international pricing mechanisms beyond the con-
trol of the Western healer (see Farmer 2005, Kleinman 
1997, Kleinman et al.1997).
Conclusion  
 
In this paper, I have argued that Bennetta (1999) makes 
a valid point in challenging the romantic notions of tropi-
cal rain forests as pharmaceutical wonderlands and local 
healers as medical savants, but find his generalizations 
to be ethnocentric justifications for disregarding the rights 
and knowledge of those who live in the forest. Rather, I 
have suggested that while indigenous medicines may not 
necessarily come from rainforests to the extent many be-
lieve, and that indigenous healers may or may not have 
extensive knowledge of the native pharmacopeia, there 
remains a need to reconsider the ways in which the cul-
tural context of medicinal use is conceptualized in popular 
culture and by development and conservation planners.
More specifically, I have suggested that the concept of 
culture must be refashioned from the popular realm of all 
that is exotic and different, that which finds its way into 
Hollywood movies, National Geographic magazines, and 
middle-class home decor, and instead become more ful-
ly appreciated through contemporary anthropological ap-
proaches to culture which include a focus on social struc-
tures and relations, and their linkage to national and inter-
national political and economic networks and institutions. 
In other words, when talking about “ethnomedicine” or 
“traditional medicine,” we might gain keener insights into 
indigenous practices by considering how changing econ-
omies and social relations contribute to changing health-
care needs, and changing access to health resources. 
Moreover, through such a focus, it becomes clear that 
different people have different health needs in rainforest 
communities, and draw on differing medicines and treat-
ments, thereby dispelling notions of “traditional” medical 
practices among non-differentiated “natives” (see Etkin 
1996:162-163 for a discussion on syncretic medical sys-
tems). Such differences are significantly influenced by so-
cial factors such as class, caste, gender, and age, and not 
just “ethnicity,” or “tradition.” As such, concepts such as 
“medical systems,” are not bounded systems related ex-
clusively to healing and religious beliefs, but also include 
agricultural and other economic systems, with complex 
histories and linkages to the state and international institu-
tions that shape health and health care in multiple ways.
 
At the same time, I have argued that in our efforts to re-
spect intellectual property rights in the most equitable 
manner possible, the industrialized world may very well 
benefit from the knowledge and resources of the tropical 
world. But without extending the medical knowledge and 
resources of the wealthiest sectors of the world -- and ac-
cess to these resources -- to those who live in the forest 
and treat their diseases with plants instead of pills, we will 
inevitably fall short of reaching any equitable or ethical in-
tellectual exchange.
 
Finally, as our efforts to explore “tropical” medicines and 
health continue, we must extend the concept of “culture” 
to include the changing culture of the developed world, 
and reflect upon the multitude of ways in which “develop-
ment,” “conservation,” and “globalization” foster social in-
equalities that exacerbate or cause poor health and death 
for so many in the rainforests of the world. “Modern” medi-
cine clearly saves lives, and I’ve yet to meet an Ameri-
can or European advocate of “traditional” medicine who 
would celebrate the use of leaves or tree bark for their 
own bout of scabies or their own child’s malaria, but at the 
same time, the ways in which people are “modernized,” 
shapes the ways in which “traditions” are employed and 
perceived.
 
While Bennetta (1999) might regard “rainforest clap-trap” 
as a justification for dismissing the concerns of those liv-
ing in the rainforest, I would suggest that “rainforest clap-
trap” is all the more reason that the needs of the world’s 
poorest peoples -- many of whom live in tropical rainfor-
ests -- be prioritized over the needs of the endangered 
biodiversity of the tropics. What for Benetta may be “clap-
trap,” is an image that has captured the hearts and imagi-
nations of many in the developed world for whom rainfor-
est remedies are more than likely decoratively-packaged 
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lotions and oils that help our skin to glow, and ease our 
minds that the inflated price we may have paid will ben-
efit a small tribal village very far away. The reality is that 
our ability to purchase rainforest remedies in the “devel-
oped” world has been made possible by a long historical 
process of conquest and domination of the tropical worlds 
and their peoples. To truly extent human rights to those 
living in the “endangered” rain forests that remain, those 
of us in the richest parts of the world might ask how the 
medicines we use can be made more readily available 
to indigenous peoples, rather than how their medicines 
might be made more readily available to us. 
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